Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors

Recommended

Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program

Cognitrex Inc. Announces Market Entry of Enterprise LearningOS Platform Led by Founder Hana Dhanji

Bombardier to Provide Six Multi-role Aircraft to Support the Royal Canadian Air Force